Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review

Inappropriate and excessive use of antibiotics is responsible for the rapid development of antimicrobial resistance, which is associated with increased patient morbidity and mortality. There is an urgent need to explore new antibiotics or alternative antimicrobial agents. <i>S. aureus</i>...

Full description

Saved in:
Bibliographic Details
Main Authors: Michał Michalik, Adrianna Podbielska-Kubera, Agnieszka Dmowska-Koroblewska
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/1/81
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587722680696832
author Michał Michalik
Adrianna Podbielska-Kubera
Agnieszka Dmowska-Koroblewska
author_facet Michał Michalik
Adrianna Podbielska-Kubera
Agnieszka Dmowska-Koroblewska
author_sort Michał Michalik
collection DOAJ
description Inappropriate and excessive use of antibiotics is responsible for the rapid development of antimicrobial resistance, which is associated with increased patient morbidity and mortality. There is an urgent need to explore new antibiotics or alternative antimicrobial agents. <i>S. aureus</i> a commensal microorganism but is also responsible for numerous infections. In addition to innate resistance to β-lactam antibiotics, <i>S. aureus</i> strains resistant to methicillin (MRSA) often show resistance to other classes of antibiotics (multidrug resistance). The advancement of phage therapy against MRSA infections offers a promising alternative in the context of increasing antibiotic resistance. Therapeutic phages are easier to obtain and cheaper to produce than antibiotics. However, there is still a lack of standards to ensure the safe use of phages, including purification, dosage, means of administration, and the quantity of phages used. Some bacteria have developed defense mechanisms against phages. The use of phage cocktails or the combination of antibiotics and phages is preferred. For personalized therapy, it is essential to set up large collections to enable phage selection. In the future, the fight against MRSA strains using phages should be based on a multidisciplinary approach, including molecular biology and medicine. Other therapies in the fight against MRSA strains include the use of endolysin antimicrobial peptides (including defensins and cathelicidins). Researchers’ activities also focus on the potential use of plant extracts, honey, propolis, alkaloids, and essential oils. To date, no vaccine has been approved against <i>S. aureus</i> strains.
format Article
id doaj-art-8ada0afc7ac64e6cb5c652ab52d32c27
institution Kabale University
issn 1424-8247
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-8ada0afc7ac64e6cb5c652ab52d32c272025-01-24T13:45:19ZengMDPI AGPharmaceuticals1424-82472025-01-011818110.3390/ph18010081Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—ReviewMichał Michalik0Adrianna Podbielska-Kubera1Agnieszka Dmowska-Koroblewska2MML Medical Centre, Bagno 2, 00-112 Warsaw, PolandMML Medical Centre, Bagno 2, 00-112 Warsaw, PolandMML Medical Centre, Bagno 2, 00-112 Warsaw, PolandInappropriate and excessive use of antibiotics is responsible for the rapid development of antimicrobial resistance, which is associated with increased patient morbidity and mortality. There is an urgent need to explore new antibiotics or alternative antimicrobial agents. <i>S. aureus</i> a commensal microorganism but is also responsible for numerous infections. In addition to innate resistance to β-lactam antibiotics, <i>S. aureus</i> strains resistant to methicillin (MRSA) often show resistance to other classes of antibiotics (multidrug resistance). The advancement of phage therapy against MRSA infections offers a promising alternative in the context of increasing antibiotic resistance. Therapeutic phages are easier to obtain and cheaper to produce than antibiotics. However, there is still a lack of standards to ensure the safe use of phages, including purification, dosage, means of administration, and the quantity of phages used. Some bacteria have developed defense mechanisms against phages. The use of phage cocktails or the combination of antibiotics and phages is preferred. For personalized therapy, it is essential to set up large collections to enable phage selection. In the future, the fight against MRSA strains using phages should be based on a multidisciplinary approach, including molecular biology and medicine. Other therapies in the fight against MRSA strains include the use of endolysin antimicrobial peptides (including defensins and cathelicidins). Researchers’ activities also focus on the potential use of plant extracts, honey, propolis, alkaloids, and essential oils. To date, no vaccine has been approved against <i>S. aureus</i> strains.https://www.mdpi.com/1424-8247/18/1/81<i>Staphylococcus aureus</i>MRSAmultidrug resistancemethicillin resistancephagesantimicrobial peptides
spellingShingle Michał Michalik
Adrianna Podbielska-Kubera
Agnieszka Dmowska-Koroblewska
Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review
Pharmaceuticals
<i>Staphylococcus aureus</i>
MRSA
multidrug resistance
methicillin resistance
phages
antimicrobial peptides
title Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review
title_full Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review
title_fullStr Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review
title_full_unstemmed Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review
title_short Antibiotic Resistance of <i>Staphylococcus aureus</i> Strains—Searching for New Antimicrobial Agents—Review
title_sort antibiotic resistance of i staphylococcus aureus i strains searching for new antimicrobial agents review
topic <i>Staphylococcus aureus</i>
MRSA
multidrug resistance
methicillin resistance
phages
antimicrobial peptides
url https://www.mdpi.com/1424-8247/18/1/81
work_keys_str_mv AT michałmichalik antibioticresistanceofistaphylococcusaureusistrainssearchingfornewantimicrobialagentsreview
AT adriannapodbielskakubera antibioticresistanceofistaphylococcusaureusistrainssearchingfornewantimicrobialagentsreview
AT agnieszkadmowskakoroblewska antibioticresistanceofistaphylococcusaureusistrainssearchingfornewantimicrobialagentsreview